We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

116 hedge funds and large institutions have $102M invested in Cardiff Oncology in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more call options, than puts

Call options by funds: $3.03M | Put options by funds: $929K

194% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 17

6.39% more ownership

Funds ownership: 42.23% → 48.62% (+6.4%)

1% less funds holding

Funds holding: 117 → 116 (-1)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

17% less capital invested

Capital invested by funds: $122M → $102M (-$20.4M)

Holders
116
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
50
Reduced
17
Closed
17
Calls
$3.03M
Puts
$929K
Net Calls
+$2.1M
Net Calls Change
-$1.23M

Top Buyers

1
William Blair & Company
William Blair & Company
Illinois
+$5.81M
2
BlackRock
BlackRock
New York
+$3.96M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.28M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.72M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.63M

Top Sellers

1
O
OrbiMed
New York
-$3.81M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.21M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.1M
4
IC
Ikarian Capital
Texas
-$1.95M
5
UBS Group
UBS Group
Switzerland
-$778K
Name Holding Trade Value Shares
Change 		Change in
Stake
NS
101
NBC Securities
Alabama
$3K +$3.96K +1,000 New
Group One Trading
102
Group One Trading
Illinois
$2.74K -$41.8K -10,563 -92%
MWA
103
Moser Wealth Advisors
Washington
$2.53K – – –
SS
104
SBI Securities
Japan
$2.31K +$312 +79 +12%
CA
105
Clearstead Advisors
Ohio
$2.2K – – –
SCM
106
Sterling Capital Management
North Carolina
$1.99K -$791 -200 -24%
VWWMG
107
Vermillion & White Wealth Management Group
Pennsylvania
$1.57K – – –
Carson Wealth (CWM LLC)
108
Carson Wealth (CWM LLC)
Nebraska
$1K +$316 +80 +25%
AF
109
Allworth Financial
California
$290 – – –
NA
110
NewEdge Advisors
Louisiana
$254 – – –
Northwestern Mutual Wealth Management
111
Northwestern Mutual Wealth Management
Wisconsin
$151 -$237 -60 -56%
TWD
112
True Wealth Design
Ohio
$44 +$55 +14 New
CPG
113
Cornerstone Planning Group
New Jersey
$15 – – –
FRA
114
Front Row Advisors
California
$6 – – –
EWA
115
EverSource Wealth Advisors
Alabama
$6 +$8 +2 New
RJA
116
Ross\Johnson & Associates
Minnesota
$3 – – –
Point72 Asset Management
117
Point72 Asset Management
Connecticut
– -$2.21M -508,438 Closed
Renaissance Technologies
118
Renaissance Technologies
New York
– -$2.1M -483,090 Closed
IC
119
Ikarian Capital
Texas
– -$1.95M -450,000 Closed
BFM
120
Boothbay Fund Management
New York
– -$564K -129,960 Closed
AIC
121
AWM Investment Company
New York
– -$462K -106,435 Closed
American Century Companies
122
American Century Companies
Missouri
– -$234K -53,955 Closed
JGC
123
J. Goldman & Co
New York
– -$205K -47,250 Closed
XT
124
XTX Topco
Cayman Islands
– -$177K -40,763 Closed
Wolverine Trading
125
Wolverine Trading
Illinois
– -$96.8K -24,482 Closed
2 3 4
5
6

CRDF Hedge Fund Activity: Q1 2025 in Review

116 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2025, worth a combined $102M — down 17% from $122M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CRDF and 16 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 50 added.

The largest buyer was William Blair & Company, adding an estimated $5.81M. The largest seller was OrbiMed, cutting an estimated $3.81M.

  • 116 institutional investors held Cardiff Oncology (CRDF) as of Q1 2025, down from 117 in Q4 2024.
  • Funds reported $102M of Cardiff Oncology stock for Q1 2025, down 17% quarter-over-quarter.
  • 16 funds opened new Cardiff Oncology positions in Q1 2025 and 17 closed out, a net change of -1 holder.
  • The largest Cardiff Oncology buyer in Q1 2025 was William Blair & Company, an estimated $5.81M added.
  • The largest Cardiff Oncology seller in Q1 2025 was OrbiMed, an estimated $3.81M sold.

Based on aggregated 13F filings for Q1 2025.